Legal & General Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.81M Buy
97,532
+8,905
+10% +$256K ﹤0.01% 1827
2025
Q1
$2.97M Sell
88,627
-312
-0.4% -$10.5K ﹤0.01% 1770
2024
Q4
$4.55M Buy
88,939
+18,443
+26% +$943K ﹤0.01% 1620
2024
Q3
$3.6M Buy
70,496
+1,738
+3% +$88.8K ﹤0.01% 1724
2024
Q2
$3.08M Buy
68,758
+4,806
+8% +$215K ﹤0.01% 1759
2024
Q1
$2.99M Buy
63,952
+9,847
+18% +$461K ﹤0.01% 1757
2023
Q4
$1.93M Buy
54,105
+502
+0.9% +$17.9K ﹤0.01% 1974
2023
Q3
$1.59M Buy
53,603
+15,755
+42% +$469K ﹤0.01% 1997
2023
Q2
$682K Buy
37,848
+15,301
+68% +$276K ﹤0.01% 2352
2023
Q1
$362K Buy
22,547
+6,601
+41% +$106K ﹤0.01% 2405
2022
Q4
$292K Buy
15,946
+685
+4% +$12.5K ﹤0.01% 2475
2022
Q3
$300K Buy
15,261
+831
+6% +$16.3K ﹤0.01% 2476
2022
Q2
$269K Buy
14,430
+189
+1% +$3.52K ﹤0.01% 2531
2022
Q1
$313K Buy
14,241
+390
+3% +$8.57K ﹤0.01% 2524
2021
Q4
$393K Buy
13,851
+4,275
+45% +$121K ﹤0.01% 2489
2021
Q3
$202K Buy
9,576
+4,483
+88% +$94.6K ﹤0.01% 2689
2021
Q2
$96K Buy
5,093
+858
+20% +$16.2K ﹤0.01% 2751
2021
Q1
$64K Buy
4,235
+230
+6% +$3.48K ﹤0.01% 2745
2020
Q4
$57K Hold
4,005
﹤0.01% 2765
2020
Q3
$63K Sell
4,005
-1,124
-22% -$17.7K ﹤0.01% 2612
2020
Q2
$90K Buy
5,129
+3,257
+174% +$57.2K ﹤0.01% 2559
2020
Q1
$28K Sell
1,872
-390
-17% -$5.83K ﹤0.01% 2784
2019
Q4
$54K Buy
2,262
+419
+23% +$10K ﹤0.01% 2784
2019
Q3
$28K Hold
1,843
﹤0.01% 2992
2019
Q2
$46K Buy
1,843
+380
+26% +$9.49K ﹤0.01% 2808
2019
Q1
$33K Buy
1,463
+410
+39% +$9.25K ﹤0.01% 2884
2018
Q4
$31K Hold
1,053
﹤0.01% 2886
2018
Q3
$30K Buy
+1,053
New +$30K ﹤0.01% 3023